256 related articles for article (PubMed ID: 38142645)
1. Two in one: the emerging concept of bifunctional antibodies.
Rhee K; Zhou X
Curr Opin Biotechnol; 2024 Feb; 85():103050. PubMed ID: 38142645
[TBL] [Abstract][Full Text] [Related]
2. Bispecific antibodies for viral immunotherapy.
Nyakatura EK; Soare AY; Lai JR
Hum Vaccin Immunother; 2017 Apr; 13(4):836-842. PubMed ID: 27786606
[TBL] [Abstract][Full Text] [Related]
3. Extracellular targeted protein degradation: an emerging modality for drug discovery.
Wells JA; Kumru K
Nat Rev Drug Discov; 2024 Feb; 23(2):126-140. PubMed ID: 38062152
[TBL] [Abstract][Full Text] [Related]
4. Engineering of monoclonal antibodies and antibody-based fusion proteins: successes and challenges.
Teillaud JL
Expert Opin Biol Ther; 2005 Sep; 5 Suppl 1():S15-27. PubMed ID: 16187937
[TBL] [Abstract][Full Text] [Related]
5. Bispecific antibodies in cancer immunotherapy.
Chen S; Li J; Li Q; Wang Z
Hum Vaccin Immunother; 2016 Oct; 12(10):2491-2500. PubMed ID: 27249163
[TBL] [Abstract][Full Text] [Related]
6. Bioanalytical Challenges in Support of Complex Modalities of Antibody-Based Therapeutics.
Zhu L; Glick J; Flarakos J
AAPS J; 2020 Oct; 22(6):130. PubMed ID: 33037499
[TBL] [Abstract][Full Text] [Related]
7. Bispecific antibodies for cancer therapy.
Chames P; Baty D
Curr Opin Drug Discov Devel; 2009 Mar; 12(2):276-83. PubMed ID: 19333873
[TBL] [Abstract][Full Text] [Related]
8. Bispecific antibodies: an innovative arsenal to hunt, grab and destroy cancer cells.
Grandjenette C; Dicato M; Diederich M
Curr Pharm Biotechnol; 2015; 16(8):670-83. PubMed ID: 25941884
[TBL] [Abstract][Full Text] [Related]
9. Bispecific Immunomodulatory Antibodies for Cancer Immunotherapy.
Blanco B; Domínguez-Alonso C; Alvarez-Vallina L
Clin Cancer Res; 2021 Oct; 27(20):5457-5464. PubMed ID: 34108185
[TBL] [Abstract][Full Text] [Related]
10. Emerging protein degradation strategies: expanding the scope to extracellular and membrane proteins.
Lin J; Jin J; Shen Y; Zhang L; Gong G; Bian H; Chen H; Nagle DG; Wu Y; Zhang W; Luan X
Theranostics; 2021; 11(17):8337-8349. PubMed ID: 34373745
[TBL] [Abstract][Full Text] [Related]
11. The making of bispecific antibodies.
Brinkmann U; Kontermann RE
MAbs; 2017; 9(2):182-212. PubMed ID: 28071970
[TBL] [Abstract][Full Text] [Related]
12. Bispecific antibodies for polyclonal T-cell engagement.
Baeuerle PA; Kufer P; Lutterbüse R
Curr Opin Mol Ther; 2003 Aug; 5(4):413-9. PubMed ID: 14513685
[TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacology of bispecific antibody constructs.
Rathi C; Meibohm B
J Clin Pharmacol; 2015 Mar; 55 Suppl 3():S21-8. PubMed ID: 25707960
[TBL] [Abstract][Full Text] [Related]
14. Producing bispecific and bifunctional antibodies.
Das D; Suresh MR
Methods Mol Med; 2005; 109():329-46. PubMed ID: 15585930
[TBL] [Abstract][Full Text] [Related]
15. Bispecific Antibodies and Antibody-Drug Conjugates for Cancer Therapy: Technological Considerations.
Shim H
Biomolecules; 2020 Feb; 10(3):. PubMed ID: 32111076
[TBL] [Abstract][Full Text] [Related]
16. Recombinant bispecific antibodies for cancer therapy.
Kontermann RE
Acta Pharmacol Sin; 2005 Jan; 26(1):1-9. PubMed ID: 15659107
[TBL] [Abstract][Full Text] [Related]
17. Expanding the Boundaries of Biotherapeutics with Bispecific Antibodies.
Husain B; Ellerman D
BioDrugs; 2018 Oct; 32(5):441-464. PubMed ID: 30132211
[TBL] [Abstract][Full Text] [Related]
18. A critical evaluation of the tumor-targeting properties of bispecific antibodies based on quantitative biodistribution data.
Hemmerle T; Wulhfard S; Neri D
Protein Eng Des Sel; 2012 Dec; 25(12):851-4. PubMed ID: 22972762
[TBL] [Abstract][Full Text] [Related]
19. Bifunctional modalities for repurposing protein function.
Modell AE; Lai S; Nguyen TM; Choudhary A
Cell Chem Biol; 2021 Jul; 28(7):1081-1089. PubMed ID: 34270935
[TBL] [Abstract][Full Text] [Related]
20. Generation of dual-variable-domain immunoglobulin molecules for dual-specific targeting.
Gu J; Ghayur T
Methods Enzymol; 2012; 502():25-41. PubMed ID: 22208980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
